{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:39:46Z","timestamp":1791866386946,"version":"4.3.4"},"reference-count":37,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["098504\/Z\/12\/Z"],"award-info":[{"award-number":["098504\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101143\/Z\/13\/Z"],"award-info":[{"award-number":["101143\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107731\/Z\/15\/Z"],"award-info":[{"award-number":["107731\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,11,2]]},"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether there is an association between use of ACE inhibitors (ACEI) and angiotensin receptor blockers (ARB) and risk of acute kidney injury (AKI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>We conducted a new-user cohort study of the rate of AKI among users of common antihypertensives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>UK primary care practices contributing to the Clinical Practice Research Datalink (CPRD) eligible for linkage to hospital records data from the Hospital Episode Statistics (HES) database between April 1997 and March 2014.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>New users of antihypertensives: ACEI\/ARB, \u03b2-blockers, calcium channel blockers and thiazide diuretics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The outcome was first episode of AKI. We estimated incidence rate ratio (RR) for AKI during time exposed to ACEI\/ARB compared to time unexposed, adjusting for age, sex, comorbidities, use of other antihypertensive drugs and calendar period using Poisson regression. Covariates were time updated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 570\u2005445 participants, 303\u2005761 were prescribed ACEI\/ARB with a mean follow-up of 4.1\u2005years. The adjusted RR of AKI during time exposed to ACEI\/ARB compared to time unexposed was 1.12 (95% CI 1.07 to 1.17). This relative risk varied depending on absolute risk of AKI, with lower or no increased relative risk from the drugs among those at greatest absolute risk. For example, among people with stage 4 chronic kidney disease (who had 6.69 (95% CI 5.57 to 8.03) times higher rate of AKI compared to those without chronic kidney disease), the adjusted RR of AKI during time exposed to ACEI\/ARB compared to time unexposed was 0.66 (95% CI 0.44 to 0.97) in contrast to 1.17 (95% CI 1.09 to 1.25) among people without chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment with ACEI\/ARB is associated with only a small increase in AKI risk while individual patient characteristics are much more strongly associated with the rate of AKI. The degree of increased risk varies between patient groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-012690","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T21:11:26Z","timestamp":1482354686000},"page":"e012690","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":86,"title":["Prescription of renin\u2013angiotensin system blockers and risk of acute kidney injury: a population-based cohort study"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-410X","authenticated-orcid":false,"given":"Kathryn E","family":"Mansfield","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Bhaskaran","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"2025121600213100000_6.12.e012690.1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090740"},{"key":"2025121600213100000_6.12.e012690.2","unstructured":"Think Kidneys. Acute kidney injury: the NHS campaign to improve the care of people at risk of, or with, acute kidney injury, 2016. https:\/\/www.thinkkidneys.nhs.uk\/aki\/ (accessed Jan 2016)."},{"key":"2025121600213100000_6.12.e012690.3","first-page":"1","article-title":"International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology","volume":"6736","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"2025121600213100000_6.12.e012690.4","doi-asserted-by":"publisher","DOI":"10.1161\/hc4101.096153"},{"key":"2025121600213100000_6.12.e012690.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62459-4"},{"key":"2025121600213100000_6.12.e012690.6","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case\u2013control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"2025121600213100000_6.12.e012690.7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.101"},{"key":"2025121600213100000_6.12.e012690.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.0306-5251.2004.2188.x"},{"key":"2025121600213100000_6.12.e012690.9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05480610"},{"key":"2025121600213100000_6.12.e012690.10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05271107"},{"key":"2025121600213100000_6.12.e012690.11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jch.12795","article-title":"Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk?","volume":"18","author":"Chaumont","year":"2016","journal-title":"J Clin Hypertens"},{"key":"2025121600213100000_6.12.e012690.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303154"},{"key":"2025121600213100000_6.12.e012690.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61236-2"},{"key":"2025121600213100000_6.12.e012690.14","unstructured":"European Medicines Agency. Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted\u2014CHMP endorses PRAC recommendation. 2014. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/05\/news_detail_002107.jsp&mid=WC0b01ac058004d5c1 (accessed 18 Sep 2015)."},{"key":"2025121600213100000_6.12.e012690.15","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2013.109"},{"key":"2025121600213100000_6.12.e012690.16","unstructured":"National Institute for Health and Care Excellence. NICE clincal guideline 169: Acute kidney injury\u2014prevention, detection and management of acute kidney injury up to the point of renal replacement therapy. 2013. http:\/\/www.nice.org.uk\/nicemedia\/live\/14258\/65056\/65056.pdf (accessed 14 Aug 2015)."},{"key":"2025121600213100000_6.12.e012690.17","unstructured":"Scottish Patient Safety Programme. Medicine sick day rules card. Healthc. Improv. Scotl. 2015. http:\/\/www.scottishpatientsafetyprogramme.scot.nhs.uk\/programmes\/primary-care\/medicine-sick-day-rules-card (accessed 16 Jun 2015)."},{"key":"2025121600213100000_6.12.e012690.18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025121600213100000_6.12.e012690.19","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdt116"},{"key":"2025121600213100000_6.12.e012690.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003389"},{"key":"2025121600213100000_6.12.e012690.21","unstructured":"HSCIC. Hospital Episode Statistics. http:\/\/www.hscic.gov.uk\/hes (accessed 25 Jun 2015)."},{"key":"2025121600213100000_6.12.e012690.22","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.2.176"},{"key":"2025121600213100000_6.12.e012690.23","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199901000-00005"},{"key":"2025121600213100000_6.12.e012690.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121600213100000_6.12.e012690.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61350-6"},{"key":"2025121600213100000_6.12.e012690.26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.ajkd.2014.11.027","article-title":"CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records","volume":"66","author":"McDonald","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025121600213100000_6.12.e012690.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6650"},{"key":"2025121600213100000_6.12.e012690.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu263"},{"key":"2025121600213100000_6.12.e012690.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2350"},{"key":"2025121600213100000_6.12.e012690.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4388"},{"key":"2025121600213100000_6.12.e012690.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099825"},{"key":"2025121600213100000_6.12.e012690.32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-58"},{"key":"2025121600213100000_6.12.e012690.33","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10821011"},{"key":"2025121600213100000_6.12.e012690.34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv094"},{"key":"2025121600213100000_6.12.e012690.35","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07650713"},{"key":"2025121600213100000_6.12.e012690.36","first-page":"14","article-title":"Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care?","volume":"2","author":"Bedford","year":"2015","journal-title":"Can J Kidney Heal Dis"},{"key":"2025121600213100000_6.12.e012690.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078465"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-012690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:21:41Z","timestamp":1765873301000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-012690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,21]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1136\/bmjopen-2016-012690"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-012690","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}